Vimarsana
Biggest News Aggregation in the World

Page 4 - Planet Communications News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Planet Communications. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Planet Communications Today - Breaking & Trending Today

CANbridge to Present CAN106 Phase 1 Data at the European Hematology Association 2022 Congress - Vimarsana News

CANbridge to Present CAN106 Phase 1 Data at the European Hematology Association 2022 Congress

Press release content from Business Wire. The AP news staff was not involved in its creation.

Source: apnews.com
CANbridge Pharmaceuticals Appoints Pauline Li as Senior Vice President of Clinical Development and Operations - Vimarsana News

CANbridge Pharmaceuticals Appoints Pauline Li as Senior Vice President of Clinical Development and Operations

Press release content from Business Wire. The AP news staff was not involved in its creation.

Source: apnews.com
Tie-up to build EV charging infrastructure - Vimarsana News

Tie-up to build EV charging infrastructure

The growing electric vehicle (EV) industry has encouraged the SET-listed companies Planet Communications Asia and Ekarat Engineering to team up for an EV charging infrastructure business.

CANbridge Pharmaceuticals CAN108 New Drug Application (NDA), for Alagille Syndrome, Accepted by China's National Medical Products Administration - Vimarsana News

CANbridge Pharmaceuticals CAN108 New Drug Application (NDA), for Alagille Syndrome, Accepted by China's National Medical Products Administration

Beijing, China, Cambridge, Massachusetts - CANbridge Pharmaceuticals Inc., a leading China-based global biopharmaceutical company committed to the research, development and commercialization of... | January 20, 2022

CANbridge Pharmaceuticals CAN108 New Drug Application (NDA) for Alagille Syndrome Accepted by China's National Medical Products Administration - Vimarsana News

CANbridge Pharmaceuticals CAN108 New Drug Application (NDA) for Alagille Syndrome Accepted by China's National Medical Products Administration

Press release content from Business Wire. The AP news staff was not involved in its creation.

Source: apnews.com